Many Medicare Cancer Patients Now Have Much Lower Out-Of-Pocket Costs – RamaOnHealthcare

Many Medicare Cancer Patients Now Have Much Lower Out-Of-Pocket Costs – RamaOnHealthcare

Tens of thousands of Medicare beneficiaries who are cancer patients have substantially lower out-of-pocket costs for their prescription drugs, thanks to a key provision included in the Inflation Reduction Act.When people think about the IRA’s drug pricing measures, they’re more likely to be familiar with the Medicare price negotiation aspect than the redesign of Medicare’s [...]